Dechra enjoys solid trading
26th February 2013
PHARMACEUTICALS group Dechra has said trading in its veterinary products segment has continued to be robust as it reports solid first half revenues.
However, the group said the second half could be a tough period because of various factors – not just economic.
Dechra operates the Dales Pharmaceuticals business in Skipton.
It said in its half year results statement: “We remain cautious regarding the overall economic environment and are also conscious of the pressure on European veterinarians to self......for the full story register now for free or login below...
Read Next News Archive
- Register Now For Free!